Carbinoxamine Maleate Tablet
Product Images NDC 44523-825

4 FDA label images from Biocomp Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbinoxamine Maleate (NDC 44523-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocomp Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Carbinoxamine Maleate, displaying the molecular framework including rings and substituents, alongside its molecular formula C4H4O4.*
FDA Label Image

Picture (Biocomp Logo Cm)

Picture (Biocomp Logo Cm)
Label showing the manufacturer information for Carbinoxamine Maleate 4 mg oral tablets, produced for BioComp Pharma, Inc. in San Antonio, Texas. The label includes the BioComp Pharma logo and a product code BCP016R1225D.*
FDA Label Image

Label (Label Cm)

Label (Label Cm)
Label for Carbinoxamine Maleate Tablets, USP 4 mg, containing 100 tablets in a bottle. The label includes storage instructions, prescription status (Rx Only), and the manufacturer, BioComp Pharma, Inc. The NDC number 44523-825-01 is shown on the label.*
FDA Label Image

Image (Carton Cm)

Image (Carton Cm)
Packaging label for Carbinoxamine Maleate Tablets, USP 4 mg by Biocomp Pharma, Inc. The label indicates a package size of 100 tablets, prescription only, with storage instructions at 20°C to 25°C. The label includes a barcode, storage and pharmacist instructions, and a caution to keep medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.